"The U.S. Food and Drug Administration today approved a new use for Xiaflex (collagenase clostridium histolyticum) as the first FDA-approved medicine to treat men with bothersome curvature of the penis, a condition known as Peyronie's disease."...
- Patient Information:
Details with Side Effects
Patients should be told about the possible occurrence of symptoms related to postural hypotension, such as dizziness or syncope, when beginning therapy or when increasing dosage strength of CARDURA XL (doxazosin mesylate extended release tablets) . Patients should be cautioned about driving, operating machinery, or performing hazardous tasks during this period, until the drug's effect has been determined.
Patients should be informed that CARDURA XL (doxazosin mesylate extended release tablets) extended release tablets should be swallowed whole. Patients should not chew, divide, cut, or crush tablets. Patients should not be concerned if they occasionally notice in their stool something that looks like a tablet. In the CARDURA XL (doxazosin mesylate extended release tablets) extended release tablet, the medication is contained within a nonabsorbable shell designed to release the drug at a controlled rate. When this process is completed, the empty tablet is eliminated from the body.
CARDURA XL (doxazosin mesylate extended release tablets) should be taken each day with breakfast.
Last reviewed on RxList: 4/1/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Cardura XL Information
Cardura XL - User Reviews
Cardura XL User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.